Mucomodulator therapy in cystic fibrosis: balancing mucus clearability against the spread of airborne pathogens.
King
Malcolm
M
Pulmonary Research Group, 173 Heritage Med Res Ctr, University of Alberta, Edmonton, AB T6G 2S2, Canada. malcolm.king@ualberta.ca
Zayas
J Gustavo
JG
D003550:Cystic Fibrosis / Q000188:drug therapy / Q000503:physiopathology*; D005100:Expectorants / Q000627:therapeutic use*; D006801:Humans; D009079:Mucociliary Clearance / Q000502:physiology*; D009093:Mucus / Q000378:metabolism*
D005100:Expectorants